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ABSTRACT
Introduction: The use of corticosteroids to
reduce the post-operative sequelae of lower
third molar surgery, namely pain, swelling and
trismus, has been well studied by many
researchers over the past 6 decades. This study
reviewed the reported outcome of
corticosteroids used in controlling the above
sequalae after third molar surgery.
Materials and Methods: A PubMed, Medline,
EMBASE and Google search was undertaken of
all controlled clinical trials on the effects of
corticosteroids on pain, swelling and trismus
after lower third molar surgery. The review was
limited to studies published over the last
10 years (2006–2015).
Results: Of the 46 initially retrieved articles, 34
were finally included. Eleven studies compared
the effect of 2 similar (but different dose) or
different group of corticosteroids. Thirty-one
studies reported the effects of corticosteroids on
all sequale, 2 reported the outcome on swelling
and trismus and another 1 on swelling and pain
only. In 16 of the studies, corticosteroid use
resulted in significant reductions in pain after
third molar removal. Twenty-two out of 29
studies reported reduced swelling against
negative control while 18 out of 25 studies
reported improved mouth opening. Fourteen
studies reported the benefit of corticosteroids
on all 3 sequelae, with 71.4% resulted from the
use of methylprednisolone.
Conclusion: Although there are some
conflicting effects, the results of this analysis
shows in general the benefits derived from
short-term use of corticosteroids in relation to
pain, swelling and trismus following third
molar surgical extraction, with no side effects
observed.
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INTRODUCTION
Surgical removal of impacted lower third molars
is one of the most commonly performed
surgical procedures in any dental surgery
worldwide. Although it is a minor surgical
procedure, the common sequelae, which are
pain, swelling and trismus, can severely affect
patients’ quality of life during the immediate
post-operative period [1]. These sequelae arise as
a result of tissue inflammatory process, with
cardinal signs of inflammation that include
pain (dolor), heat (calor), redness (rubor),
swelling (tumor) and loss of function
(function laesa) [2]. There are considerable
variations from patient to patient in the
occurrence and severity of the inflammatory
symptoms.
In the past, many different approaches,
including drains, laser therapy and
medications with enzymes, muscle relaxants
or corticosteroids were clinically evaluated in an
effort to minimize these post-operative sequelae
[3–6]. The last agent, namely the
corticosteroids, have shown promising results.
Corticosteroids are available as two main
groups, the glucocorticoids and the
mineralcorticoids. It is the glucocorticoids that
are of interest here, because of their
anti-inflammatory activities with little or no
effect on fluid and electrolyte balance. The term
corticosteroids will subsequently be used in this
study to denote the former group of agents.
Corticosteroids are a class of chemicals that
includes natural steroid hormones that are
produced in the adrenal cortex of vertebrates
as well as the synthetic analogues of these
hormones. They are 21 carbon compounds
having a cyclopentanoperhydro-phenanthene
(steroid) nucleus and were first purified by Dr.
William C. Kendall, who later on, together with
Drs. Phillip S. Hench and Tadeus Reichstein,
won a Nobel Prize for Physiology or Medicine.
In 1948, Hench et al. successfully used cortisone
and adrenocorticotropic (corticotropine)
hormone to reduce the inflammatory process
of rheumatoid arthritis [7]. Following this
success, various other forms of corticosteroids
have been synthesized as scientists found that
the biologic properties of corticosteroids can be
altered quantitatively and selectively by the
substitution of certain chemical groupings and
by minor configurational changes in molecular
structure [3].
Dehydrogenation at the 1 position of the
steroid nucleus gave rise to prednisone and
prednisolone. This increased anti-inflammatory
activity four to five times. During 1957, Arth
et al. synthesized dexamethasone
(9-alpha-fluoro, 16-alpha-methylprednisolone)
which is a synthetic analogue of
methylprednisolone in which a methyl group
has been added at the carbon 16 position and a
fluorine atom at the carbon 9 position [8, 9].
The addition of fluorine at the carbon 9 position
greatly enhances the anti-inflammatory activity
of the new compound. Dexamethasone has a
milligram activity 5–10 times of predisone and
prednisolone, and 30 times that of cortisone
[10].
Corticosteroids are classified according to
their duration of action. Short-acting
glucocorticoids include cortisol
(hydrocortisone) and cortisone, with duration
of action less than 12 h and anti-inflammatory
potency of 1. Intermediate acting
glucocorticoids have duration of action of
12–36 h. They include prednisone and
prednisolone with anti-inflammatory potency
of 4, and 6-methylprednisolone and
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triamcinolone, both having anti-inflammatory
potency of 5. Dexamethasone and
betamethasone are long-acting glucocorticoids,
with duration of action greater than 36 h and
anti-inflammatory potency of 25 (Table 1) [11].
As seen in Table 1, to obtain a similar effect
of 10 mg prednisolone, one needs to prescribe
8 mg methylprednisolone, 50 mg cortisone,
40 mg hydrocortisone (cortisol), or 1.5 mg
betamethasone or dexamethasone. These doses
are twice the equivalent to the physiological
output of cortisol by the adrenal cortex in an
average individual during an average day [12].
Corticosteroids reduce inflammation via the
inhibition of phospholipase A2, which is the
first enzyme involved in the conversion of
phospholipids into arachidonic acid, therefore
blocking the synthesis of other products such as
prostaglandins, leukotrienes and substances
related to thromboxane A2 [13]. In essence,
corticosteroids stop the formation of these end
products which is a broth of potent
inflammatory mediators that causes the signs
and symptoms described above [2]. They also
have the ability to stabilize lysozyme
membranes, decrease the release of
inflammation-causing lysozymes, and decrease
the permeability of capillary which thus
prevents diapedesis, i.e. the initial leakage of
fluids from the capillaries and loss of plasma
protein into tissue space [3, 11]. There is also a
decrease in the formation of bradykinin, a
powerful vasodilating substance [3].
Strean is credited with publishing a paper
which represented the first scientific approach
to the general use of corticosteroids in dentistry
[14]. Both Strean (together with colleague,
Horton) and Spies et al. were the first to use
(hydro)cortisone for the treatment of oral
diseases related to local causes and oral
manifestations of inflammatory systemic
disease [15, 16]. However, it was an editorial
by Kenny that first suggested the use of steroids
for managing post-operative sequalae [17].
Following that, Ross and White confirmed this
anti-inflammatory effect by using oral
hydrocortisone against placebo in a double
blind study involving third molar surgeries
[18]. Since then, the use of corticosteroids for
third molar surgery had been studied
extensively in different formulations, dosings,
routes and sites of administration. These
corticosteroids include dexamethasone (per
oral/p.o.), dexamethasone acetate
Table 1 The duration of action and anti-inﬂammatory potency of glucocorticoids
Glucocorticoids Anti-inﬂammatory potency Duration of action Equivalent dose
Cortisol 1 Short (\12 h) 20
Cortisone 0.8 25
Prednisone 4 5
Prednisolone 4 Intermediate (12–36 h) 5
6-Methyl prednisolone 5 4
Triamcinolone 5 4
Dexamethasone 25 Long ([36 h) 0.75
Betamethasone 25 0.75
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(intramuscular), dexamethasone sodium
phosphate (intravenous and intramuscular),
methylprednisolone (p.o.), and
methylprednisolone acetate and
methylprednisolone sodium succinate (both
intravenous and intramuscular) [19]. An
attempt at undertaking a systematic review on
the use of corticosteroids up to September 2011
by Herrera-Briones et al. turned into a narrative
review due to the heterogeneity of many study
designs, outcome measures, and routes of drug
administration [20, 21]. Hence, this study does
not attempt to replicate their work, but instead
tries to answer some questions that arose from
the systematic analysis. Quite a number of new
reports have been published over the last
5 years, and we believe that some of them are
able to address questions relating to the
magnitude of the decrease in the clinical
symptoms on the patients’ quality of life, the
timing of drug administration, the efficacy of
administrating into the masseter muscle as
compared other sites of intramuscular
administration, and the effect of enteral intake
versus parenteral routes. This article aims to
review only studies that were carried out in the
past decade in an attempt to determine any
consistent effects of corticosteroids on swelling,
pain and trismus with the objective of
answering the following questions:
1. The effect of corticosteroids on patients’
quality of life.
2. The timing of drug administration.
3. The efficacy of administrating into the
masseter muscle as compared other sites of
intramuscular administration.
4. The effect of enteral intake versus parenteral
routes.
5. The adverse effect of corticosteroids
administration, namely acute alveolar
osteitis, post-operative infection and
nausea.
METHODS
We performed this review in the spirit of
summarizing important facts and findings
from various relevant studies and literature to
provide a state of the art update on the use of
corticosteroids in third molar surgery. The
methodology used in this study is an
adaptation from the protocol used by Ata-Ali
et al. [13]. A Pubmed, Medline, EMBASE and
Google search was undertaken of all controlled
clinical trials on the effects of corticosteroids on
pain, swelling and trismus after lower third
molar surgery. The review was limited to studies
published over the last 10 years (2006–2015).
This review included only articles that
compared the use of corticosteroids in any
formulation, dose and route/site with another
corticosteroid or negative/placebo control
group. Articles were excluded if they
contributed unclear data on the patient
selection, treatment, route of administration,
dose and surgical procedure, measurement of
sequalae or inadequate data on outcomes.
Articles that compared corticosteroids with
other drugs, intervention or treatment were
excluded, except when the corticosteroid was
administered with an adjuvant therapy related
to third molar surgery, namely an antibiotic. A
total of 34 articles were finally included
(Tables 2, 3, 4), with documentation of the
following from each of them: year of
publication, number of patients in the study
and control groups, corticosteroids
administered, dosage, route and timing of
administration, analgesic efficacy,
anti-swelling effect, and effect on trismus.
Compliance with Ethics Guidelines
This article is based on previously conducted
studies and does not involve any new studies of
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human or animal subjects performed by any of
the authors.
RESULTS
During the past 10 years, the commonly studied
corticosteroids for use in third molar surgery
were dexamethasone (17 reports),
methylprednisolone (10 reports), prednisolone
(2 reports) and betamethasone (1 report). Four
other studies compared two different steroids.
Corticosteroids had been administered via
various routes that included intravenous,
intramuscular (masseter, deltoid or gluteus),
submucosal, endo-alveolar and oral.
Results Involving Dexamethasone
Dexamethasone was first tested to control
edema and to decrease trismus and pain after
oral surgical procedures in 1965 [10], and since
then, there has been a surge in popularity for its
use in oral surgical procedures. It is one of the
most frequently studied and used
corticosteroids in oral and maxillofacial
surgery [22–38] (Table 2). In early studies, it
was usually given intramuscularly, and Messer
and Keller [3] were of the opinion that the
masseter muscle made a good site to receive
injections because of its proximity to the third
molar surgical site.
Fast forward to this millennium, newer
methods of delivery have been adopted.
Graziani et al. in 2006 compared the efficacy
of dexamethasone given as submucosal
injection and endo-alveolar application [22].
This study showed a significant reduction in
swelling following the administration of
submucosal dexamethasone and the
placement of endo-alveolar dexamethasone
post-surgically. It was reported that
endo-alveolar application of 4 mg
dexamethasone significantly reduced trismus
but this was not the case with submucosal
injection. In addition, the low-dose
dexamethasone powder applied
endo-alveolarly reduced post-operative pain
significantly when compared to others. This
study introduced the endo-alveolar approach
for administrating corticosteroid which has the
benefit of easy placement, and providing a
localized effect with reduced systemic side
effects of corticosteroids. A further study on
endo-alveolar application was later performed
once and this study confirmed its benefit [23].
The following year, Grossi et al. compared
the efficacy of increasing the dosage of
dexamethasone to 8 mg, as compared to the
4 mg used by Graziani et al. [22, 24].
Submucosal injection was given at the buccal
tissue adjacent to the surgical site and was
usually given after local anesthesia of the area
had been achieved. This technique was easy and
safe to perform, comfortable to patients and
produce a localized more than a systemic one
[22]. Grossi et al. found no significant difference
between the dexamethasone and the control
groups in reducing post-operative pain and
trismus, although submucosal dexamethasone
resulted in significantly less facial swelling on
the second day post-operative [24]. The latter
finding was supported by a post-operative
symptom severity (PoSSe) scale with the
control group reporting more changes in
appearance than the study group. They
concluded that 8 mg dexamethasone was not
superior to 4 mg dexamethasone and
recommended the use of the lower dose of
dexamethasone to reduce post-surgical sequelae
following third molar surgery. This
recommendation concurs with that suggested
by Graziani et al. [22].
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Using the enteral approach, Laureano Filho
et al. in 2008 compared the efficacy of different
doses of dexamethasone given 1 h
pre-operatively [25]. They found a significant
reduction of post-operative sequelae with the
use of a higher dose, i.e. 8 mg of
dexamethasone. The finding from this study
differed from that reported by 2 previous
authors who reported no significant benefit of
giving a high dose of dexamethasone [22, 24].
As the corticosteroid was given via an enteral
route, it has to undergo absorption in the
gastrointestinal tract. So a higher dosage will
definitely provide a higher load factor following
absorption. This finding is in contrast to an
early study half a century ago when Linenburg
reported that an even lower dose 3 mg of oral
dexamethasone, taken as 3 divided doses over
2 days, with the first dose taken 1/2 h
pre-surgery, was effective in reducing swelling
and trismus [10]. Do note, however, that
Laureano Filho et al. gave only one single
dose, as compared to Linenberg’s sustained
prescription over 2 days. Despite the
significant findings of Laureano Filho et al.’s
work, a conclusion as whether oral 4 mg
dexamethasone was significantly effective
could not be made since there was no negative
control in this study [25].
Majid presented 2 reports on the effects of
dexamethasone in 2011. In one of the reports,
which was co-authored with Mahmood, he
compared the effect of submucosal and
intramuscular injection of 4 mg
dexamethasone after third molar surgery in 30
subjects [26]. Both routes produced significantly
less swelling and pain than control. Submucosal
dexamethasone was also reported to
significantly reduce trismus on the first
post-operative day. They suggested that
submucosal injection had the advantage of
reducing trismus because of its localized effect.
Since both routes of administration provided
the same results with regards to swelling and
pain, they were of the opinion that the
submucosal route might perhaps be a better
choice due to its ease of administration and the
localized effect at the surgical site. The small
sample size (10 subjects per study group) was
the main limitation of this study. However, a
subsequent study with a 50% larger sample
using the same combinations 4 years later
showed that the submucosal route was indeed
more effective in minimizing not only
post-operative trismus but also swelling and
pain, than intra-muscular (deltoid) injection
[38]. Majid increased the number of subjects to
11 in each study group to arrive at a second
report, which also studied the effect of
submucosal and intramuscular injection of
dexamethasone after third molar surgery on
patients’ clinical sequalae. He added the
measurement on the quality of life (QoL) [27].
The results were found to be similar to the
earlier study, where both submucosal and
intramuscular injections of 4 mg
dexamethasone given just after surgery
resulted in significant improvement of
swelling and pain, and also in QoL measures
when compared to control. Like the previous
study, only the submucosal group showed
significant improvement of trismus when
compared with control. Majid concluded that
submucosal dexamethasone offered significant
positive effects on clinical and QoL recovery.
In the same year, Deo and Shetty studied the
efficacy of single submucosal injection of a
higher dose (8 mg) of dexamethasone given
prior to third molar surgery [28]. They found
that dexamethasone was significantly effective
in reducing swelling and trismus on the second
day post-operative. Dexamethasone also
prolonged the duration of analgesia, resulting
in the dexamethasone group consuming their
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first analgesic significantly later than the
control group. However, there was no overall
significant difference in pain perception
between the study group and saline control.
The limitation of this study was the fact that
both groups of samples were given ice-pack and
ibuprofen post-operatively. This may explain
why no difference in pain perception was
observed post-operatively, as the
anti-inflammatory effect of ibuprofen is more
efficacious for pain control purposes. Elsewhere,
a randomized controlled trial was carried out by
Antunes et al. to compare the efficacy of 8 mg
dexamethasone administered using 2 different
routes, oral versus intramuscular (masseter)
injection [29]. They found no significant
differences between the two dexamethasone
groups in reducing post-operative pain,
swelling and trismus, where both modes were
better than control group. The advantage of
intramuscular masseter injection would be its
close proximity to the surgical site, hence
possibly providing some localized effect
although it cannot be ruled out that this
injection provided a systemic effect equal to
oral dosing [29].
In 2012, Boonsiriseth et al. reported an
almost similar approach in a study that
compared the efficacy of intramuscular
dexamethasone and oral dexamethasone in
reducing the sequelae of third molar surgery
[30]. The only difference was that the
intramuscular injection was given into the
deltoid muscle which was a distance from the
oral cavity. Hence, the effect of dexamethasone
was purely systemic. They found that no
significant difference was noted between both
groups, similar to the report by Antunes et al.
[29]. Based on the findings of these 2 studies, it
appears that the anti-inflammatory effect of
intramuscular dexamethasone was more likely
to be of systemic rather than local effect, as the
absorption of dexamethasone via the masseter
and deltoid muscle produced similar effects.
Klongnoi et al. conducted a study to investigate
the effects of intramuscular dexamethasone
given 1 h pre-emptive in reducing pain,
swelling and trismus [31]. Pain and swelling
were significantly reduced with corticosteroid
but it was not effective in reducing trismus [31].
Although intramuscular administration into
the deltoid muscle was easy and accessible, it
is painful, and absorption varies depending on
local blood flow.
In the following year, Bortoluzzi et al.
studied the incidence of post-operative
complications of alveolar osteitis and alveolar
infection, in addition to the usual sequalae
following third molar surgery [32]. They used
two drugs, namely oral 8 mg dexamethasone
and 2 g amoxicillin, in various combinations
where either of both the drugs can be present or
absent altogether. In essence, there was a group
with both drugs present, 1 group with
dexamethasone, 1 group with amoxicillin and
1 group where neither drugs were given.
Surprisingly, they found no significant
difference between groups in terms of
post-operative swelling, pain and trimus. This
may have been caused by the use an ice-pack
and the prescription of paracetamol and sodium
diclofenac as post-operative analgesics. In
addition, the measure of swelling and trismus
were based on patient reporting. As no clear
benefit could be observed, they recommended
that antibiotic and corticoid prophylaxis should
not be administered routinely for third molar
surgeries involving healthy and young patients.
In the same year, Nair et al. and Warraich
et al. conducted independent studies at two
different centers to evaluate the efficacy of
pre-emptive 4 mg dexamethasone given as
submucosal infiltrations [33, 34]. While both
authors concluded that this regime significantly
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reduced post-operative swelling, they differed in
reducing pain and trismus. Warraich et al. [34]
found dexamethasone was significantly
beneficial in reducing pain and trismus. Their
patients also reported increased satisfaction
with the use of dexamethasone [34], probably
because these patients suffered less from the
sequelae of third molar surgery. The
post-operative regime of analgesic prescribed
may have contributed to the difference in the
findings of trismus and pain between these 2
studies. Nair et al. prescribed diclofenac sodium
75 mg twice a day for 3 days, while Warraich
et al. prescribed ibuprofen 600 mg 3 times a day
on Day 1, twice a day on Day 2 and once daily
on Day 3 and Day 4. In contrast to Warraich
et al.’s regime, the constant dosage in Nair
et al.’s study produced sustained plasma level of
analgesic which rendered better pain control
and subsequently improved the ability to open
the mouth in both the study and control
groups. This may cause the study group to
report no additional beneficial effect of
dexamethasone when compared with the
control.
In continuity to their earlier work, Majid and
Mahmood [23] became the first researchers to
compare the effect of giving post-operative
dexamethasone using 5 different routes of
administration, namely intramuscular
injection, intravenous injection, oral tablets,
submucosal injection and endo-alveolar
application. They reported no significant
differences among groups for all the
parameters of swelling, pain and trimus in
subjects given 4 mg dexamethasone. They
found that, to control swelling, the best
improvement was obtained via the
intravenous route, followed by the
intramuscular, submucosal, oral and
endo-alveolar routes in a descending order on
the first post-operative day. Interestingly, they
found that the endo-alveolar group showed
better improvement on Day 3. In comparison,
the submucosal route provided slight advantage
on Day 1, although the effect on trismus was
comparable among treatment groups. Again,
they found that endo-alveolar dexamethasone
showed a better effect on trismus at the
subsequent intervals of Day 3 and Day 7. With
respect to pain, intravenous administration was
reported to be the best at all intervals, followed
by endoalveolar, submucosal, oral and
intramuscularroutes in descending order. In
summary, their results seemed to favor the
intravenous and endo-alveolar routes,
although other means of administration
appeared to provide comparable results.
In 2014, another study similar to Nair et al.’s
and Warraich et al.’s was undertaken by Ehsan
et al. to examine the pre-emptive effect of
submucosal infiltration of 4 mg
dexamethasone on post-operative swelling and
trismus only [35]. Their findings support the
results reported by Deo and Shetty and
Warraich et al., but Ehsan et al. did not study
the effect of dexamethasone on post-operative
pain and their analgesic regime was not
described. In the same year, Agostinho et al.
compared the effect of 4 mg and 12 mg
dexamethasone in reducing post-operative
sequelae [36]. The latter dosage was three
times the lowest effective dosage of 4 mg
reported elsewhere. Their findings concurred
with that reported by Grozzi et al. and Graziani
et al. where a higher dosage of dexamethasone
did not offer a better outcome. Thus, based on
their findings, they suggested that the lowest
dose possible to achieve an anti-inflammatory
effect should always be prescribed.
Recently, Chaudary et al. compared the
pre-emptive effect of 4 mg intravenous
dexamethasone against an oral administration
of 8 mg dexamethasone [37]. They found that
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both routes of administration were equally
effective in reducing post-operative pain,
swelling and trismus. This is because an oral
corticosteroid such as dexamethasone at 8 mg
has a very high enteral absorption rate that is
comparable with intravenous application [39].
Hence, oral dexamethasone is a good
alternative to the intravenous route in patients
who do not wish to receive an injection.
Over the last decade, only 1 study has looked
into the effect of betamethasone. Marques et al.
in 2014 studied the effect of a post-operative
submucosal betamethasone 12 mg injection on
the sequelae of third molar surgery [40].
Surprisingly, betamethasone which is of the
same potency as dexamethasone showed no
significant effect in reducing post-operative
swelling, pain and trismus at all. This finding
is in contrast to that reported by Chopra et al.
who studied the effects of several drugs, one of
which was betamethasone, given orally three
times a day following third molar surgery [6].
We disagree with the authors’ proposal that
tissue manipulation affected the concentration
and absorption of the injected drug as one of
the explanation for their findings, since the
injection was given after the surgery, where no
further tissue manipulation was carried out. We
agree with the authors that more study on the
effect of betamethasone needs to be carried out
to ascertain its effects in reducing post-operative
sequelae since betamethasone has the same
potency as dexamethasone, and therefore
should theoretically render similar results
clinically.
In summary, dexamethasone has proven to
be an effective agent for reducing pain, swelling
and trismus to a certain degree, irrespective of
the route and the timing of administration. The
lowest dose possible to achieve an
anti-inflammatory effect was 4 mg. No serious
adverse effects, namely acute alveolar osteitis,
post-operative infection and nausea, have been
reported following the administration of
dexamethasone in the study samples.
Variations in the results may be because of
differences in surgical methods, differences in
individual response to treatment and
differences in the methodology used.
Results Involving Prednisolone
Prednisolone and methylprednisolone have
been tested in a number of studies (Table 3)
[39, 41–51]. Two reports coming from the 1970s
showed that preemptive administration of
intravenous methylprednisolone or oral
prednisolone significantly reduced
post-operative edema, pain and trismus
[52, 53]. Prednisolone and methylprednisolone
are five times more potent than cortisone, with
an intermediate duration of action (see Table 1).
Prednisolone is available in oral, topical and
injection forms, while methylprednisolone is
usually administered via the intravenous or
intramuscular route [41, 42]. Although the
possibility of topical (endo-alveolar)
application has been described for
dexamethasone, this approached has yet to be
attempted on prednisolone.
Throughout the last 10 years, only 2 studies
have looked into the effects of prednisolone.
Tiigimae-Saar et al. reported that post-operative
administration of 30 mg prednisolone relieved
pain, swelling and trismus more than
non-administration of prednisolone in the
control group [43]. On the other hand, Kang
et al. tried to determine the effect of lower doses
of prednisolone on the sequelae of third molar
surgery [44]. They compared the efficacy of
10 mg and 20 mg prednisolone taken orally in
more than 200 patients. Their results showed
that both dosages had no significant impact on
the sequelae of surgical removal of third molars.
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Hence, they concluded that a dosage of 20 mg
or lower may not provide relief of
post-operative sequelae. It is suspected that
such a finding may have resulted from the use
of ice-packs for 2 post-operative days and the
prescription of ibuprofen 200 mg orally
preoperatively, immediately after surgery, and
every 8 h until the third post-operative day,
which masked the effect of prednisolone. In
addition, this study was carried out by the use of
a questionnaire with patients being asked to
report changes in post-operative symptoms for
6 days [44].
There have been 12 studies that attempted to
determine the effects of methylprednisolone on
the sequelae of third molar surgery. In 2006,
Mico´-Llorens et al. conducted a study to
determine the efficacy of pre-operative gluteal
injection of methylprednisolone in controlling
the sequelae of third molar surgery [41]. They
reported that methylprednisolone significantly
reduced post-operative swelling and trismus on
the second post-operative day. As for
post-operative pain, its significant effect was
only recorded at 6 h post-surgery. Subsequently,
the pain difference between the
methylprednisolone group and control was
not significant. Gluteal injection may be
effective but this method may not be
convenient in certain clinical settings. Two
years later, the same group, now lead by
Vegas-Bustamante, performed a similar study,
but instead gave post-operative masseteric
injection of 40 mg methylprednisolone [42].
They found that this regime significantly
reduced post-operative swelling and trismus
for up to 7 days, and provided better pain
control for 3 days post-operative.
In the following year, Gataa and Nemat
compared the effectiveness of two modes of
pre-emptive administration of 10 mg
methylprednisolone, namely enteral and
submucosal injection [46]. They reported that
methyprednisolone taken orally 1 h
pre-operative was more effective than
submucosal injection in controlling swelling
and pain. They reasoned that this was due to
the slow absorption of the injected form of
methylprednisolone, coupled with its biological
half-life of 18–36 h. As pain usually peaks 6–8 h
and edema reaches its maximum size about
36–48 h after third molar surgery, the injected
(localized) methylprednisolone therefore has
less effect due to the slower onset of its action.
This suggestion, however, needs further
investigation as the only other group of
researchers who investigated the effectiveness
of submucosal injection of methyprednisolone
after them reported contradictory results.
Ashraf et al. reported that submucosal
injection was equally as effective as
intramuscular (gluteal) injection in providing
relief of swelling, pain and trismus after third
molar surgery [47]. Do note, however, that they
administered a high dose of 125 mg
methylprednisolone to their patients, probably
because they were influenced by the dose used
by Al-Khateeb et al. [55]. Besides them, the only
other authors who compared the effect of
submucosal and intramuscular injection were
Majid and Mahmood both reporting favorable
effects on swelling and pain using
dexamethasone, but at a lower equivalent dose
[23, 26].
In 2011, Kaur et al. conducted a study similar
to that performed by Vegas-Bustamante et al. to
evaluate the effect of a single 40 mg dose of
methylprednisolone, injected into the masseter
muscle following surgical removal of impacted
third molars [45]. They also reported that
methylprednisolone had significantly reduced
post-operative pain, swelling and trismus. The
findings from 3 studies confirmed that
masseteric injection is a good and effective
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way to administer methylprednisolone
[41, 42, 45]. This observation was confirmed in
2013 by Chaurand-Lara and Facio-Uman˜a who
reported that the benefit of giving a masseteric
intramuscular injection of 20 mg
methylprednisolone for immediate
post-operative control of pain and swelling
[48]. The limitations of their study were that
the site of this split mouth study was not
randomized and only the subjects were
blinded to the injection.
Acham et al. were the only authors who
studied the effect of pre-emptive body
weight-dependant doses of oral
methylprednisolone in reducing post-operative
pain, swelling and trismus [39]. The reason why
they administered methylprednisolone orally
was because of its extremely high enteral
absorption rate that is comparable with
intravenous application. Similar to the results
obtained from previous studies using
methylprednisolone, it was significantly
effective in reducing all 3 post-operative
sequalae, especially pain. There was
significantly less pain suffered by patients
given methylprednisolone throughout the
7 days of study. They acknowledged the use of
NSAIDs post-operatively may partly contribute
to this good result. The authors reported no
adverse effect related to the drug, but the fact
that patients were covered with pantoprazole
made it difficult to find any gastrointestinal
effect of relatively high doses of
methylprednisolone.
Koc¸er et al. in 2014 attempted to determine
the best route for prescribing effective
methylprednisolone [49]. They compared the
efficacy of 20 mg methylprednisolone in
reducing post-operative swelling and trismus
delivered through masseteric intramuscular
injection, oral intake and intravenous delivery.
They reported less trismus in all patients given
methylprednisolone regardless of its forms or
routes. Of these routes, masseteric (local)
injection proved to be superior in reducing
swelling but trismus was slightly better
controlled by intravenous methylprednisolone,
although this finding was not statistically
significant. From these findings, we can
deduce that masseteric injection of
methylprednisolone would make a good mode
of administration taking into consideration the
ease of administration, patient comfort and its
better post-operative effect [49]. Results from
this study reconfirmed the findings of 4
previous studies.
Instead of the mode of administration, Vyas
et al. studied the timing of drug administration
[51]. They compared the pre-emptive and
post-operative effects of intramuscular
methylprednisolone and reported that
pre-emptive administration of 40 mg
methylprednisolone was significantly better in
reducing facial swelling and trismus and, to some
extent, pain [51]. Pre-emptive
methylprednsolone provided early advantage in
pain relief, but later was not different than
post-operative intramuscular injection as the
latter become redistributed in the circulation.
These findings were not unexpected as
corticosteroids were given 1 h before the onset of
inflammatory response, thereby allowing
adequate time to reach the target site to prevent
the activation of the arachidonic acid pathway
following injury [39]. Methylprednisolone
acetate used in this study has a sustained release
effect due to its formulation, thus providing a
prolonged anti-inflammatory effect that
prevented rebound swelling from happening. In
this study, no negative control was used, therefore
anti-inflammatory effect of post-operative
administration of methylprednisolone cannot
be entirely appreciated, unlike in the reports by
Vegas-Bustamante et al. [42] and Kaur et al. [45].
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Selvaraj et al. in 2014, compared different
sites for intramuscular injection. They injected
40 mg methylprednisolone into masseter and
gluteus muscles of the same subjects undergoing
a cross over study and found no significant
difference in the effects when using these two
sites [50]. Both sites of administration were
equally effective in reducing patients’
post-operative sequalae of swelling, pain and
trismus. This finding supports the suggestion of
the systemic effect of intramuscular injections of
corticosteroids as shown by Boonsiriseth et al.
[30] and Antunes et al. [29], who found that the
absorption of drugs via the masseter and deltoid
muscles produced the same effect as oral intake.
This again supports the suggestion that the effect
of masseter muscle injection is systemic instead
of localized. So, if given a choice between the
masseter and other sites, it is more likely that the
masseter will be the preferred site of injection as
it is more convenient and comfortable to the
surgeons and patients. It also holds the
advantage of being a painless site for steroid
injection as the masseteric muscle usually gets
anesthetized during the provision of local
anesthetic agents for third molar surgery.
In summary, prednisolone and
methylprednisolone have proven to be
effective agents for reducing swelling and
trismus, and to some extent pain, irrespective
of the route and the timing of administration.
The lowest dose possible to achieve
anti-inflammatory effect appears to be 40 mg.
No serious adverse effects, namely acute
alveolar osteitis, post-operative infection and
nausea have been reported following the
administration of prednisolone or
methylprednisolone in the study samples.
Variations in the results obtained may be the
results of differences in surgical approaches,
differences in individual response to treatment
and differences in the methodology adopted.
Result Comparing Different
Corticosteroids
For some unknown reasons, there are few
studies that have attempted to compare the
efficacy of two different groups of
corticosteroids (Table 4). So far, there have
been 3 studies undertaken to compare the
efficacy of dexamethasone versus
methylprednisolone in controlling the
post-operative sequalae of third molar surgery
[54, 56, 58]. In 2012, Loganathan and
Srinivasan [56] compared the efficacy of single
doses of methylprednisolone (40 mg) and
dexamethasone (4 mg) injected into the
masseter muscle about 15 min prior to surgery.
They found no significant difference between
the two groups in alleviating the post-operative
sequale of third molar surgery.
In contrast, Alcaˆntara et al. and Darwade
et al. reported different findings [54, 57]. Both
studies compared the efficacy of oral
administration of 8 mg dexamethasone against
40 mg methylprednisolone in reducing
post-operative discomforts. These dosages were
chosen as they were approximately equivalent
to 200 mg of cortisol. Both studies reported
significant reductions in swelling and trismus in
the dexamethasone group as compared to the
methylprednisolone group. The former group
was also reported to have less pain when
compared to the methylprednisolone group,
although the difference was not statistically
significant. The beneficial effect of
dexamethasone was due to its longer duration
of action and greater potency compared to
methylprednisolone.
Most recently, Zerener et al. [58] has
compared the post-operative submucosal
injection of dexamethasone and triamcinolone
acetonide. This is the only study that has tried
to determine the effect of injecting
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triamcinolone acetonide submucosally. In
agreement with many other studies, both
corticosteroids were significantly better in
controlling post-operative swelling.
Dexamethasone was better in reducing
post-operative pain and trismus on the first
and third post-operative days, while
triamcinolone acetonide controlled pain better
on the third and seventh post-operative days
compared to control. Triamcinolone acetonide
significantly reduced trismus throughout the
period of assessment compared to control,
while dexamethasone was effective during the
early post-operative days. The difference in the
time of best effect may have resulted from the
different half-life of each steroid. However,
there was no significant difference between
the two corticosteroids in reducing
post-operative swelling, pain and trismus.
Nevertheless, the authors suggested that
triamcinolone acetonide makes a good
alternative to dexamethasone in controlling
the post-operative sequale of third molar
surgery.
In summary, more studies should be carried
out in the future to compare different types of
corticosteroids to reveal the one with the lowest
effective dosage and easiest route of
administration for use in routine oral surgical
procedures. Dexamethasone appears to be more
potent and effective than methylpredinsolone
clinically. The use of triamcinolone acetonide
though is promising, and needs further
randomized and control studies. A summary of
the outcomes of various researches cited here is
presented in Tables 2, 3 and 4.
DISCUSSION
Altogether, this review found that a single
administration of corticosteroids was often
effective in reducing post-operative pain,
swelling and trimus, in contrast to previous
reports that emphasized the need for pulse
therapy or a longer duration of dosing to extend
the benefits of the drug [12, 19, 52]. Although
doses of corticosteroids will usually clear the
blood stream in less than 24 h, the
immunosuppresive anti inflammatory effects
may persist up to 3 days, thus explaining why
even a single dose is adequate for third molar
surgery [59]. However, there have been three
reports that found that corticosteroids were not
better than negative control [32, 40, 44]. One
possible explanation as to why these studies
found that negative control was equally as good
is possibly because the patients were
stimulated through the
hypothalamic-pituitary-adrenocortical pathways
to increase their secretion of steroids, mostly
hydrocortisone, during third molar surgery [59].
Another reason is the suboptimal dose provided,
as reported by Kang et al. [44]. One way to
determine the level of corticosteroids in the
body is to measure them; another way is by
checking the peripheral eosinophil count, as a
study by Thorn et al. found that a fall in the
peripheral eosinophil count is one of the most
significant effects of cortisones on the cellular
elements of the blood [60]. The magnitude of the
fall varied with the dosage and route of
administration. Ross and White reported the
monitoring of peripheral eosinophil counts in
their third molar study in 1958 [18], but no other
researchers have done so since then. They
reported an interesting fact discovered in the
control group in which 6 patients (out of 22) were
found to have a better than 50% reduction in their
eosinophil counts, and, interestingly enough, all
of these patients fell in the moderate edema
group. This suggested that those patients
produced excessive corticosteroids as a reaction
to the trauma of surgery, hence resulting in less
facial swelling.
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Hydrocortisone (cortisol) is the natural
corticosteroid produced by the body, with
normal daily production in a normal adult
being between 15 and 30 mg, but up to
300 mg can be supplied in times of crisis
[12, 59, 61]. To achieve an anti inflammatory
effect, corticosteroids have to be given at higher
doses, above the basal secretion. However, there
was not one single study that can answer the
question on the best dosage, best route of
administration and best time to provide
corticosteroids. One fact that remains certain
is that Kang et al. [44] in 2010 showed that
prednisolone in doses of less than 20 mg was
not effective. Therefore, a higher dose is
suggested for clinical use. There follows a
detailed discussion on the route of
administration, dosage, and timing of the
surgery, as well as the effects of corticosteroids
on swelling, trismus and pain.
Route of Administration
Although intravenous administration affords
excellent and immediate plasma drug levels,
this route is infrequently used in an
outpatient clinical setting, unless patients are
receiving intravenous sedation at the same
time [19]. In fact, throughout the last
10 years, only 3 studies looked into the
effectiveness of the intravenous route as a
means to deliver corticosteroids. Chaudary
et al. compared the pre-emptive effect of
4 mg intravenous dexamethasone against an
oral administration of 8 mg dexamethasone
and found that both routes of administration
were equally effective in reducing
post-operative swelling, pain and trismus
[37]. Do note, however, that the dosage of
the oral route was twice the intravenous dose
of dexamethasone administered. A similar
effect has been reported by Majid and
Mahmood who, in 2013, compared the
intravenous route against intramuscular
injection, submucosal injection,
endo-alveolar application and per oral intake
[23]. Koc¸er et al. on the other hand showed
that the intravenous route was more effective
than intramuscular and oral intake [49]. This
finding is in contrast to a report 60 years ago,
which stated that the oral route was found to
be as effective as the intravenous route [60].
This finding also contradicts earlier reports
that suggested supplementing intravenous
corticosteroids with post-operative oral doses
up to 1 day to maximize the beneficial effect
of corticosteroids [19].
Two other routes of administration that
involve the use of needle and syringe are the
intramuscular and subcutaneous routes.
Studies have shown that intramuscular
injections are effective irrespective of the site
of injection [23, 26, 27, 29–31, 41, 42, 45,
47–49, 51]. However, injecting patients at the
gluteus or deltoid muscle may not be a
convenient procedure due to religion and
cultural restrictions. In addition, patients
may decline receiving injections away from
the oral cavity due to needlephobia. In such
cases, the masseteric muscle makes a good
alternative site. This site of administration of
the corticosteroid is convenient for the
surgeon, since the injection is carried out
close to the surgical area. For the patient, this
injection is painless as it is usually given after
the area has achieved anesthesia. In addition,
its effectiveness does not depend on the
patient’s compliance as in the case of enteral
route [29, 42, 45, 46, 48]. Several studies have
shown that corticosteroids given
submucosally are as effective as those
administered via the intramuscular route
[23, 26, 27, 38, 47]. A recent meta-analysis
study confirmed the effectiveness of submucal
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injection of dexamethasone [62] in relieving
post-operative pain and swelling, but not
trismus. There was one study that, however,
found submucosal injection was less effective
when compared to oral route [46]. This
difference may have arisen from the fact that
oral corticosteroids were given 1 h
pre-emptive, hence giving it ample time to
be circulated into the body in comparison to
the submucosal injection. Nevertheless, due to
its proximity to the surgical site, the
submucosally administered corticosteroids
will eventually be able to act on eicosanoids
that are present, hence preventing subsequent
inflammatory processes.
Another approach to introduce
corticosteroids directly to the surgical wound
was the endo-alveolar approach. So far, there
were only two study that reported the effect of
this approach, which apparently was better
than submucosal injection [22, 23]. It has
been shown that a locally applied
glucocorticoid has direct inhibitory effect on
signal transmission in nociceptive C-fibers and
ectopic neuroma discharge in injured nerve
[63]. Similar mechanism may explain for the
improvement in pain relief as reported by the
two research groups [21]. Although topical
(endo-alveolar) application has been described
for dexamethasone, this approached has yet to
be attempted on prednisolone.
Of all routes, the oral route is the most
convenient and perhaps most acceptable to the
patient. Orally administered corticosteroids has
been shown to undergo rapid and almost
complete absorption, but its efficacy and time
taken to achieve therapeutic plasma level is
questionable when compared with parenteral
administration [63]. Previous studies reported
that oral corticosteroids are best given at least
3–4 h before surgery [19]. However, current
studies show that preemptive intake 1 h before
surgery was the preferred choice and was able to
render similar desired effect [25, 29, 37, 39, 46].
Nevertheless, the study by Tiigamae-Saar et al.
[43] and Boonsiriseth et al. [30] showed that
post-operative intake of a single dose of
corticosteroids or over one day was equally
effective. This finding was supported by Majid
and Mahmood [23]. Although this route is the
most convenient way to provide
corticosteroids, it may not be practical for
patients who are fasted for the removal of
third molars under general anesthesia. This is
because the use of oral forms might cause
gastrointestinal upset, unless it is taken with
food [59]. In fact, oral intake of corticosteroids
is contraindicated for patients with
gastrointestinal problem; hence the need to
utilize other routes described above.
Timing
Based on the articles reviewed, it seems that
corticosteroids were equally effective
regardless of the timing of their
administration. However, a recent study by
Vyas et al. [51] showed that pre-emptive
administration was significantly better than
those given post-operatively. Their finding
also concurred with the conclusion made by
two previous reviews [19, 20]. This advantage
is based on the fact that corticosteroids
should be given before the onset of the
inflammatory process. Post-operative
administration may only prevent further
propagation of inflammation but is unable
to reverse inflammation that has occurred.
Nevertheless, more studies on the timing of
administration of different corticosteroids are
required to confirm the current findings, as
two groups of researchers have reported that
post-operative intake of corticosteroids was as
effective [23, 41].
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Effects on post-operative Sequalae
Although results from various studies were
inconsistent especially in reducing
post-operative pain and trismus (see below),
corticosteroids consistently produced a
favourable effect in reducing edema, i.e.
post-operative swelling. This observation has
been reported in 22 out of 29 (75.9%) studies
that showed a reduced swelling against negative
control [22–29, 31, 33–35, 39, 41–43,
45–49, 51]. It has to be borne in mind,
though, that all these studies used linear
measurement to assess facial swelling. This was
done by marking a few points on the face; for
example, the outer canthus of the eye, angle of
mandible, corner of mouth, tragus, and
symphysis, and a linear distance between two
points were measured. This technique,
although easy and cost-effective, is subjected
to errors during assessment. This may explain
the inconsistent findings in two studies [32, 40].
In fact, one study with no significant results on
swelling used patient feedback as a tool of
measurement [44]. Nevertheless, it can be
concluded that all these studies confirm to a
certain degree the anti-inflammatory effect of
various corticosteroids administered in different
dosing regimens and administration routes to
lessen swelling, and to some extent pain and
trismus, following third molar surgery.
Trismus can be a manifestation of pain,
swelling or both. Eighteen out of 25 (72.0%)
studies reported improved mouth opening
[22, 23, 25–29, 34, 35, 39, 41–43, 45–47, 49,
51]. Five groups of researchers found that
corticosteroids which were effective in
reducing swelling failed to provide similar
beneficial effects against trismus
[24, 31, 33, 48]. The dosage of corticosteroids
given to reduce trismus may be a critical factor.
One group of researchers found that oral
prednisolone of less than 20 mg was not
effective in reducing trismus [44], while two
other groups [39, 43] proved that oral
prednisolone doses of more than 20 mg were
significantly effective. All different modes of
administration have been shown to be equally
effective in reducing trismus.
One has to remember that inflammation
may only be one of the many factors leading to
trismus after a third molar surgery. Trismus may
also result from the inhibitory effect of muscle
pain, either from the masseter muscle (due to its
proximity to the surgical site) or the lateral
pterygoid muscle (due to prolonged mouth
opening during surgery or stress during
extraction). These muscles could have acted as
a feedback muscle to induce an inhibitory effect
on the motor cortex excitability, as reported on
other parts of the body [64]. This inhibitory
effect is thought to prevent further movement
of the injured site and to protect the painful
muscle. However, applying this mechanism to
the trigeminothalamic system may not be as
straightforward since both trigeminothalamic
and spinothalamic systems have different
complex functions [65]. Nevertheless, this
should be a factor to reckon with. Other
factors that may exacerbate trismus include
prolonged surgical time, traumatic extraction
and accidental injection of a local anesthetic
agent into the medial pterygoid muscle. None
of these confounding factors have been
addressed in any of the studies reviewed here.
Some reduction of post-operative pain is
generally expected following a reduction of
edema, in addition to the corticosteroids’
inhibitory effects on prostaglandins. Of the 24
studies that looked into the effect of
corticosteroids in reducing post-operative pain
after third molar removal, 16 (66.7%) reported
improved pain relief [22, 23, 26, 27, 29,
39, 42, 43, 45–48]. Fifty-six percent of these
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reports were associated with the use of
methylprednisolone as an anti-inflammatory
agent. This gives an impression that
methylprednisolone is the corticosteroid with
a better analgesic effect. However, a recent
report found that dexamethasone appeared to
have a slight advantage over
methylpredinsolone when both agents were
compared in a clinical trial. Alcˆantara et al.
[54] showed that 8 mg dexamethasone was
superior to 40 mg methylprednisolone in
reducing post-operative pain. In other studies,
the inconsistent effect on pain may lie in the
dosage of corticosteroids given. One study
found that methylprednisolone with dosages
below 20 mg appeared to be ineffective for
post-operative pain relief [44]. In comparison,
many studies have shown that
methylprednisolone, when given in higher
doses regardless of route of delivery, showed a
consistent positive result in reducing pain
[39, 41–43, 45–48, 51]. With regard to
dexamethasone, only 7 studies [22, 23, 26, 27,
29, 31, 34] reported its ability to relieve pain
while another 6 studies showed no significant
effect on pain management, as administered
using various doses and by different routes of
administration [24, 25, 27, 32, 33, 40].
Although 16 studies have shown some
reduction of pain with corticosteroids use, the
actual mechanism of this effect has yet to be
understood. In fact, earlier studies reported that
corticosteroids alone have shown no clinically
significant analgesic effect [3, 66, 67]. Worse,
the use of corticosteroids might increase the
patient’s reaction to pain by suppressing
b-endorphin levels [68]. It is well known that
analgesics such as paracetamol and NSAIDs
have a ceiling of analgesic effect, and may not
be sufficient as monotherapy after third molar
surgery. As corticosteroids act on the
prostaglandin system differently than NSAIDs
and have other anti-inflammatory effects, better
analgesia had been achieved when
corticosteroids were added to NSAIDs [69–71].
The analgesic effect of corticosteroids is
suspected to be mediated by
anti-inflammatory and immune suppressive
effects [72]. Their anti-inflammatory action
results in decreased production of various
inflammatory mediators that play a major role
in amplifying and maintaining of pain
perception. In addition, swelling that results
from surgery causes tissue tension which leads
to additional tension-induced pain [11]. The
ability of corticosteroids to reduce swelling may
amplify their analgesic effect by lessening pain
that arises from tissue tension. This suggestion
concurs with the opinion of Messer and Keller
who stated that pain was related to swelling and
that, if swelling could be controlled, the pain
would be minimal [3].
The apparent interactions between the
mechanisms of the action of NSAIDs and
steroids suggests that co-therapy may provide
beneficial inflammatory and pain relief in the
absence of side effects [70, 71, 73]. Recently,
Jarrah et al. performed a study that confirmed
the synergistic effect of corticosteroids
(dexamethasone) with ibuprofen in
controlling post-operative pain and trismus, as
opposed to corticosteroid alone [74].
It has to be noted that, in the studies
reviewed, pain was assessed subjectively and
was not the only primary outcome measured. As
a result of this, pain outcomes after third molar
surgeries varied. Pain is also dependant on
several factors such as surgical trauma and the
individual’s pain threshold and psychological
well-being [3]. Lastly, corticosteroids have also
been reported to have synergistic effects with
local anesthesia given for surgery [75]. So, it is
unclear at this point whether the reduced pain
experienced by patients has arisen from their
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synergistic effect with local anesthetic agents
given or from their synergistic effect with the
analgesics prescribed. These suggestions warrant
further detailed study with pain as the primary
outcome to confirm the current observation.
The adverse effects of a single dose of
corticosteroid appear to be very low as all
studies reviewed hardly reported any adverse
effects. This concurs with the finding of
previous studies that have demonstrated the
safety of a a single dose or short-term protocol
of less than 3–5 days [59, 61]. In fact, Valergakis
et al. [76] observed no increase in the number of
complications, even with extended
post-operative use up to 5 days at 12 mg per
day of steroids, including dexamethasone. In
comparison, the side effects of prolonged
corticosteroid use are well known, and they
include increased appetite, excessive weight
gain, development of abdominal girth,
insomnia, increased sweating, mild hirsutism,
cutaneous purpura, and slight facial rounding
[77], none of which are expected to occur
following their use for third molar surgery.
These adverse effects are often cited as the
reason against the use of corticosteroids in
routine clinical dental practice [13]. It is about
time dentists rethink their reluctance to use
short-term corticosteroids, especially with just
one dose given peri-operatively.
CONCLUSION
From these studies, it can be summarized that
the use of corticosteroids in third molar surgery
appears promising in reducing post-operative
discomforts or sequelae. Fourteen studies
reported the benefit of corticosteroids on all 3
sequelae, with 71.4% resulting from
methylprednisolone use. It is almost certain
that swelling and to some extent trismus will be
significantly reduced with the use of
corticosteroids. It appears that the potential
analgesic effect of corticosteroids holds promise
to enhance their further acceptance into
routine dental practice, although their role in
pain control remains debatable. More studies
should therefore be carried out to confirm if the
analgesic effect results from the synergistic
effects with NSAIDs and/or local anesthetic
agents. Assessment of the sequelae should be
done with more accurate and precise assessment
tools so that the results of these future studies
will have an impact on the best route and
corticosteroids to be used, taking into
consideration its efficacy and side effects as
well as cost and whether its usage is
economically feasible to be adopted in routine
practice.
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